The landscape of managing diabetes is advancing with the introduction of skin-applied GLP-1 therapy. These novel patches offer a likely simpler alternative to injections for individuals living with type 2 diabetes . These patches deliver glucagon-like peptide-1 directly through the dermis , avoid